Company
SingaporeGlaxoSmithKline Biologicals, Singapore, Singapore – FDA Inspections
Inspection records and compliance data for GlaxoSmithKline Biologicals in Singapore. 2 FDA inspections on record, 1 Form 483, last inspected August 05, 2025.
Company Profile
This profile covers GlaxoSmithKline Biologicals based in Singapore, Singapore.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected November 8, 2022. Last inspected August 5, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 5, 2025 | Not classified | Biologics | 1280789 |
| November 8, 2022 | VAI | Biologics · Vaccines and Allergenic Products | 1193493 |
FDA documents
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
GlaxoSmithKline Biologicals
FEI Number
3016007176
Address
10 Tuas South Avenue 8, Singapore, Singapore
Country
Singapore
ID: a1983e6a-fbe9-4c98-8efb-39f62ca09624